EMA Curtails Use of Fluoroquinolone, Quinolone Antibiotics
A committee for the European Medicines Agency (EMA) has recommended suspending entirely or restricting the use of fluoroquinolone and quinolone antibiotics because of the risk for “disabling and potentially permanent” adverse effects, the agency announced...
Bayer to cut internal drug R&D work, axing hundreds of researchers while looking to partners as it unveils plan to slash 12,000 jobs
Bayer is pushing ahead with plans to restructure its drug R&D business and cut 900 research staffers as part of a broad plan to slash a total of 12,000 employees in a worldwide revamp. Details on the changes in R&D — something that’s been rumored to be in the...
Novartis plans more ‘autonomy’ for Sandoz. But don’t confuse that with a spinoff: report
Just one day after Novartis laid out plans for its long-expected spinoff of its eye unit Alcon, the Swiss pharma giant found itself fending off a rumor that it also intends to wave goodbye to its generics business, Sandoz. The rumor started when a Swiss newspaper...
AbbVie’s Orilissa makes its uterine fibroids case with double phase 3 win
AbbVie’s Orilissa (elagolix) snagged its first FDA approval over the summer, and now it’s looking to make it two. On Wednesday, the Illinois drugmaker and partner Neurocrine Biosciences unveiled details from a pair of phase 3 studies showing that the drug—already...LATEST NEWS
More anti-epidemic measures eased today
Bulgaria resumes the “green corridor” walk-in vaccination scheme
30,000 Bulgarians receive jabs against Covid-19 in last three days
CureVac’s mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage
COVID-19 vaccine players will split $100B in sales and $40B in profits, with Moderna leading the way: analyst